REFERENCES
1. Mastrangelo G, Coindre JM, Ducimetière F, et al. Incidence of soft
tissue sarcoma and beyond: a population-based prospective study in 3
European regions[J]. Cancer, 2012, 118(21):5339-5348.
2. Vlentetie M, Litiere S, Rizzo E, et al. Outcome of chemotherapy in
advanced synovial sarcoma patients: Review of 15 clinical trials from
the European Organisation for Research and Treatment of Cancer Soft
Tissue and Bone Sarcoma Group; setting a new landmark for studies in
this entity[J]. Eur J Cancer, 2016, 58:62-
72.
3. Wang S, Song R, Sun T, et al. Survival changes in patients with
synovial sarcoma 1983-2012[J]. J Cancer, 2017, 8(10):1759.
4. Vlenterie M, Ho VK, Kaal SE, et al. Age as an independent prognostic
factor for survival of localised synovial sarcoma patients[J]. Br J
Cancer, 2015, 113(11):1602-1606.
5. Shi W, Indelicato DJ, Morris CG, et al. Long-term treatment outcomes
for patients with synovial sarcoma: a 40-year experience at the
University of Florida[J]. Am J Clin Oncol, 2013, 36(1):83-88.
6. Krieg AH, Hefti F, Speth BM, et al. Synovial sarcomas usually
metastasize after > 5 years: a multicenter retrospective
analysis with minimum follow-up of 10 years for survivors[J]. Ann
Oncol, 2011, 22(2):458-467.
7. Stanelle EJ, Christison-Lagay ER, Wolden SL, et al. Pulmonary
metastasectomy in pediatric/adolescent patients with synovial sarcoma:
an institutional review[J]. J Pediatr Surg, 2013, 48(4):757-763.
8. Sista F, Penna AD, Abruzzese V, et al. Intestinal Intussusception by
Monophasic Synovial Sarcoma: Case Report and Literature Review.
Chirurgia (Bucur). 2015 Jul-Aug;110(4):391-5. PMID: 26305207.
9. Nielsen TO, Poulin NM, Ladanyi M. Synovial sarcoma: recent
discoveries as a roadmap to new avenues for therapy. Cancer Discov. 2015
Feb;5(2):124-34.
10. Tanaka M, Homme M, Yamazaki Y, et al. Cooperation between SS18-SSX1
and miR-214 in Synovial Sarcoma Development and Progression. Cancers
(Basel). 2020 Jan 30;12(2):324.
11. Jerby-Arnon L, Neftel C, Shore ME, et al. Opposing immune and
genetic mechanisms shape oncogenic programs in synovial sarcoma. Nat
Med. 2021 Feb;27(2):289-300.